blog

2021: A Look Inside Our Crystal Ball (part two)

By Elizabeth Gargill on Tue, Dec 22, 2020 | 7 min read

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

2021: A Look Inside Our Crystal Ball (part one)

By Elizabeth Gargill on Mon, Dec 21, 2020 | 5 min read

 

As part of our Crystal Ball series, we asked BBK Worldwide President Matt Kibby to comment on the clinical research landscape and to share his predictions for 2021.

Matt Kibby, Principal, President

Is there a particular trend that you expect to have a significant impact on the industry in the coming year?

 

With COVID-19 dominating the headlines for much of 2020, one might expect that a key development for clinical R&D in 2021 will be the continued integration and expansion of services that support the hybridization / decentralization of clinical trials. Keeping trial participants – who tend to be older and at greater risk for complications from COVID-19 – away from clinical trial sites not only reduces the risk of SARS-COV-2 infection, but also offers the possibility of enrichment of the clinical trial experience; reduces the overall visit and expense burden for patients; and, moreover, reduces the trial burden on clinical trial site healthcare professionals.

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Matt Kibby, Clinical Trial Patient Travel, 2021 Predictions, 2021, Underserved Populations

How COVID-19 Is Changing Clinical Trial Patient Travel

By Mike Johnson on Thu, Jun 18, 2020 | 6 min read

 

We recently sat down with BBK’s Director of RSG Services Mike Johnson to discuss how clinical trial patient travel has been impacted by COVID-19 and how BBK's travel program RSG® Arrive has responded.

Topics: Patient Travel, RSG Arrive, COVID-19, Mike Johnson, RSG Services, Clinical Trial Patient Travel

 
Subscribe To Our Blog